enVVeno Medical Corporation
NVNO
$0.39
-$0.01-1.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -2.43% | 10.96% | 5.73% | -0.63% | -2.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.94% | 6.03% | -2.79% | -5.59% | -7.93% |
| Operating Income | 1.94% | -6.03% | 2.79% | 5.59% | 7.93% |
| Income Before Tax | -3.42% | -11.99% | 3.55% | 7.22% | 11.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.42% | -11.99% | 3.55% | 7.22% | 11.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.42% | -11.99% | 3.55% | 7.22% | 11.68% |
| EBIT | 1.94% | -6.03% | 2.79% | 5.59% | 7.93% |
| EBITDA | 1.71% | -6.36% | 2.61% | 5.52% | 7.94% |
| EPS Basic | 19.01% | 15.52% | 34.21% | 41.12% | 45.65% |
| Normalized Basic EPS | 24.83% | 20.99% | 34.31% | 40.35% | 43.61% |
| EPS Diluted | 19.01% | 15.52% | 34.21% | 41.12% | 45.65% |
| Normalized Diluted EPS | 24.83% | 20.99% | 34.31% | 40.35% | 43.61% |
| Average Basic Shares Outstanding | 27.53% | 31.06% | 39.40% | 50.09% | 60.67% |
| Average Diluted Shares Outstanding | 27.53% | 31.06% | 39.40% | 50.09% | 60.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |